Review article: Acute superior mesenteric vessel ischaemia: A review of clinical practice and biomarkers

Emerg Med Australas. 2023 Feb;35(1):14-17. doi: 10.1111/1742-6723.14145. Epub 2022 Dec 12.

Abstract

A patient with acute occlusion of the superior mesenteric vessels resulting in superior mesenteric vessel ischaemia (SMVI) who presents to the ED with abdominal pain and unremarkable abdominal examination risks delay in diagnosis and treatment with adverse outcome. A comprehensive literature search was performed, and the evidence was reviewed. To-date, there are no accurate biomarkers of SMVI and so, heightened awareness among ED staff and rapidly actioning diagnostic imaging and surgical referral will help fast-track the patient with SMVI to surgical management. Management of SMVI is challenging and requires ongoing communication. Prompt surgical intervention may help reduce mortality and morbidity in SMVI. SMVI is associated with significant mortality and morbidity. With the lack of accurate biomarkers, diagnosis and management is challenging and requires heightened awareness among ED staff for prompt surgical referral and intervention.

Keywords: acute abdomen; diagnosis; imaging; mesenteric ischaemia; superior mesenteric artery.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Humans
  • Ischemia* / diagnosis
  • Ischemia* / etiology
  • Ischemia* / surgery
  • Mesenteric Artery, Superior / surgery
  • Mesenteric Vascular Occlusion* / complications
  • Mesenteric Vascular Occlusion* / diagnosis
  • Mesenteric Vascular Occlusion* / surgery

Substances

  • Biomarkers